Human Microbiome Market (By Diseases – Cancer, Diabetes, Obesity, Acute Diarrhea or Metabolic Disorders, Autoimmune Disorders, Mental Disorders, Atopic Dermatitis and other diseases, By Technology- Cell Culture Technology, Omics Technology, High-Throughput Technology and Computational Tools, By Product – Consumables and Instruments, By End-Use –Prebiotics, Probiotics, Other Probiotic Supplements, Foods, Medical Foods, drugs and Diagnostic services)– Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2021-2031

Our human body is basically made of millions of host gene and genomes along with trillions of resident microbes. Surprisingly, this microbiome is a unique combination of viruses, bacteria and fungi and have come into limelight just 15 years ago. Microbiologists were surprised to find its power of changeability, which is becoming a powerful tool to treat many diseases in respect with our wellbeing. Today microbiome based medical applications are the best opted line of defense against pathogenic diseases or to combat side-effects of antibiotics. Science of microbiome has gifted us amazing enzymes, probiotics and prebiotics with immense potential to reduce gastro intestinal disorders and other ailments.

Human microbiome based therapies has gained marvelous success in the arena of vaccine development, microbial research, dietary supplements and pharmaceuticals. Human microbiome market is going to flourish in the coming years, owing to its effectiveness in treating the diseases in a controlled and customized manner. For e.g. fecal transplants and bacteriotherapy.Though many diseases are occurring due to disturbed microbiomes,yetmicrobiome-based medical therapies and applications are being highly preferred.

Unbalanced lifestyle, surge in autoimmune disorders, diarrheal infections among all age groups, demand for early diagnosis of diseases, budding demand for human microbiomes for drug innovations and rising geriatric population with less immunity are some of the attributing factors for the growing human microbiome market.

However, lack of trained professionals in research field and stringent government policies are acting as restraining factors to this market.

Theglobalhuman microbiome market has been categorized into many vital segments such as by diseases, technology, products, end-use and geographical boundaries.

Based on diseases type, the market has been classified into cancer, diabetes, obesity, acute diarrhea or metabolic disorders, autoimmune disorders, mental disorders, atopic dermatitis and other diseases.The diabetes disease is dominating this segment presently; however, cancer is expected to take its place as the leading disease in the coming years.

By technology, it has segments namely cell culture technology, omics technology, high-throughput technology and computational tools.The cell culture technology is estimated to grow at the highest CAGR among other technologies.

Based on product, the human microbiome market has been bifurcated into consumables and instruments.Here; owing to the highest sale of consumable products, the consumables section is expected to hold the largest share of the market along with the highest growth rate.

On the basis of end-use, the market has been segmented into prebiotics, probiotics, other probiotic supplements, foods, medical foods, drugs and diagnostic services.The diagnostics section is dominating in this category; owing to more adaptability of patients for human microbiome based diagnostic methods and services and need for early diagnosis for many auto immune disorders.

By geography, the global human microbiome market has been classified into five regions namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.Due to presence of prebiotic and probiotic manufacturers and government support in human microbiome based research, Europe is estimated to grab the major share of the global human microbiome market by the end of forecast period; followed by North America.

In terms of growth rate, Asia Pacific is expected to witness the fastest CAGR among all regionsduring the forecast period. This is owing to lesser but steady acceptance of human microbiome based products, awareness about diagnostics and rising concern about medical foods.

The globalhuman microbiome market is quite competitive with key players and many new regional playerspenetrating the current market with competitive pricing and newer biotechnological innovations.

Some of the major players in the global human microbiome market are ActoGeniX, DuPont, Metabiomics Corporation, MicroBiome Therapeutics LLC, Optibiotix Health PLC, Seres Therapeutics, Second Genome, Inc., ViThera Pharmaceuticals, Yakult Honsha Co.

Global Human Microbiome Market: By Diseases

• Cancer
• Diabetes
• Obesity
• Acute Diarrhea or Metabolic Disorders
• Autoimmune Disorders
• Mental Disorders
• Atopic Dermatitis and
• Other Diseases

Global Human Microbiome Market: By Technology

• Cell Culture Technology
• Omics Technology
• High-Throughput Technology and
• Computational Tools

Global Human Microbiome Market: By Product

• Consumables
• Instruments

Global Human Microbiome Market: By End-Use

• Prebiotics
• Probiotics
• Other Probiotic Supplements,
• Foods
• Medicated Foods
• Drugs and
• Diagnostic services

Global Human MicrobiomeMarket: By Geography

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • U.K.
  • Italy
  • France
  • Germany
  • Russia
  • Spain
  • Rest of Europe
• Asia Pacific
  • India
  • China
  • Japan
  • Australia
  • Rest of Asia Pacific
• Middle East and Africa
  • GCC
  • South Africa
  • Rest of Middle East and Africa
• Latin America
  • Brazil
  • Rest of Latin America